These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Myasthenogenicity of the main immunogenic region and endogenous muscle nicotinic acetylcholine receptors. Luo J; Lindstrom J Autoimmunity; 2012 May; 45(3):245-52. PubMed ID: 21950318 [TBL] [Abstract][Full Text] [Related]
8. Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice. Paas-Rozner M; Dayan M; Paas Y; Changeux JP; Wirguin I; Sela M; Mozes E Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2168-73. PubMed ID: 10681457 [TBL] [Abstract][Full Text] [Related]
9. Injection of inactive Bordetella pertussis and complete Freund's adjuvant with Torpedo californica AChR increases the occurrence of experimental autoimmune myasthenia gravis in C57BL/6 mice. Maruta T; Oshima M; Mosier DR; Atassi MZ Autoimmunity; 2017 Aug; 50(5):293-305. PubMed ID: 28548588 [TBL] [Abstract][Full Text] [Related]
10. IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease. Moiola L; Galbiati F; Martino G; Amadio S; Brambilla E; Comi G; Vincent A; Grimaldi LM; Adorini L Eur J Immunol; 1998 Aug; 28(8):2487-97. PubMed ID: 9710226 [TBL] [Abstract][Full Text] [Related]
11. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis. Lindstrom JM; Einarson BL; Lennon VA; Seybold ME J Exp Med; 1976 Sep; 144(3):726-38. PubMed ID: 182896 [TBL] [Abstract][Full Text] [Related]
12. Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designs. Losen M; Martinez-Martinez P; Molenaar PC; Lazaridis K; Tzartos S; Brenner T; Duan RS; Luo J; Lindstrom J; Kusner L Exp Neurol; 2015 Aug; 270():18-28. PubMed ID: 25796590 [TBL] [Abstract][Full Text] [Related]
13. Acetylcholine receptor-specific immunosuppressive therapy of experimental autoimmune myasthenia gravis and myasthenia gravis. Luo J; Lindstrom J Ann N Y Acad Sci; 2018 Feb; 1413(1):76-81. PubMed ID: 29377167 [TBL] [Abstract][Full Text] [Related]
14. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies. Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897 [TBL] [Abstract][Full Text] [Related]
15. Pathogenic autoimmunity to affinity-purified mouse acetylcholine receptor induced without adjuvant in BALB/c mice. Jermy A; Beeson D; Vincent A Eur J Immunol; 1993 Apr; 23(4):973-6. PubMed ID: 8458383 [TBL] [Abstract][Full Text] [Related]
16. Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment. Pachner AR Yale J Biol Med; 1987; 60(2):169-77. PubMed ID: 3495075 [TBL] [Abstract][Full Text] [Related]
17. Animal models of myasthenia gravis. Christadoss P; Poussin M; Deng C Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis. Losen M; Stassen MH; Martínez-Martínez P; Machiels BM; Duimel H; Frederik P; Veldman H; Wokke JH; Spaans F; Vincent A; De Baets MH Brain; 2005 Oct; 128(Pt 10):2327-37. PubMed ID: 16150851 [TBL] [Abstract][Full Text] [Related]
19. Novel animal models of acetylcholine receptor antibody-related myasthenia gravis. Tüzün E; Allman W; Ulusoy C; Yang H; Christadoss P Ann N Y Acad Sci; 2012 Dec; 1274():133-9. PubMed ID: 23252908 [TBL] [Abstract][Full Text] [Related]
20. B7-1 costimulatory molecule is critical for the development of experimental autoimmune myasthenia gravis. Poussin MA; Tüzün E; Goluszko E; Scott BG; Yang H; Franco JU; Christadoss P J Immunol; 2003 Apr; 170(8):4389-96. PubMed ID: 12682276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]